Endocyte to Begin Trial of Prostate Cancer Treatment

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)

West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is moving forward with its recently-acquired late-stage prostate cancer therapy. The company says it will soon begin a phase 3 trial for PSMA-617, which it says could potentially lead to an early approval of the treatment.

Endocyte says the phase 3 VISION trial for PSMA-617 will include two interim assessments of efficacy. The company expects to begin enrollment in the trial in the second quarter and begin the first interim assessment in the second half of 2019.

Endoycte acquired the therapy in a $12 million deal with Germany-based ABX GmbH last October. At that time, the company said it hoped to complete the trial stages for PSMA-617 as early as 2020.

"Following a successful End of Phase 2 meeting with the FDA, we are excited to launch the VISION trial, a phase 3 registration trial of PSMA-617 in patients with prostate cancer,” said Mike Sherman, chief executive officer of Endocyte. "After extensive collaboration with prostate cancer specialists around the world, the robust and sophisticated VISION trial design will be attractive to patients and physicians when we begin enrollment in the second quarter of 2018. We expect 2018 to be a critical year of execution for us, as we will not only initiate VISION, but also bring our adaptor-controlled chimeric antigen receptor t-cell (CAR T-cell) program into the clinic in the fourth quarter of 2018."

The company is also reporting a full-year net loss of $55.1 million in 2017, compared to a net loss of $43.9 million the previous year. However, the company's net loss for the fourth quarter narrowed to $8.6 million, compared to $11.1 million during the same quarter in 2016.

  • Perspectives

    • Richardson is a practice lead with Centric Consulting.

      How to Create Consistent and Positive Customer Experiences with Your Brand

      Everyone knows that keeping the consumer happy is the first priority. The importance of considering the customer’s experience in all areas of engaging with your business, not just customer service is becoming even more clear. I’m seeing an increasing number of my peers in the marketing world take ownership of the customer experience with their brands. As a result, we’re all learning how to borrow and...



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • (image courtesy of The Times of Northwest Indiana)

      U.S. Steel Updates Layoff Notice to State

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has updated the State of Indiana regarding its previously announced layoffs at the East Chicago Tin Mill. The company says 314, rather than 307, workers will be displaced when the mill is idled this fall. 

    • Red Star announced plans to expand and add 18 jobs.

      Larwill Medical Device Maker to Expand, Add Jobs

      A Whitley County-based medical device maker has announced plans to expand its facility in Larwill which should mean new jobs. Red Star Contract Manufacturing Inc. says it will invest $1.6 million in real estate improvements and additional equipment and will create 18 new jobs by 2022. 

    • Regal Beloit is closing in Valparaiso. (photo courtesy; The Times of Northwest Indiana)

      Valpo Bearings Plant to Close, Eliminating 160+ Jobs

      Wisconsin-based Regal Beloit Corp. and the union representing workers have reached an agreement about the closing of a helicopter bearing factory in Valparaiso. According to our partners at The Times of Northwest Indiana, the decision will cost between 160 to 170 workers their jobs. 

    • (WISH-TV Photo)

      Clif Bar Expands Indy Bakery

      California-based Clif Bar & Co. has completed a $10 million expansion of its commercial bakery in Indianapolis. The company says the project involved a more sustainable redesign of the facility for its employee-owners with a greater focus on energy efficiency.

    • AM General & Fiat Chrysler announce plans to build military grade Jeep Gladiator pickup trucks.

      AM General, FCA Collaborate on New Military Grade Jeep

      Nearly 80 years since the first jeep rolled off the assembly line, and helped support American soldiers throughout World War II, it appears the trusted four-wheel-drive machine may be making a comeback in the U.S. military. South Bend-based AM General LLC has teamed up with Fiat Chrysler Automobiles to build military-grade versions of the 2020 Jeep Gladiator pickup truck.